Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × nimotuzumab × Gynecologic × Clear all

Phase

Status

Unknown 3 Not yet recruiting 2 Completed 2 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 3 Gynecologic 1

Conditions

Uterine Cervical Neoplasms 1

Interventions

pembrolizumab 40 Paclitaxel 40 Carboplatin 37 olaparib 25 Magnetic Resonance Spectroscopy 20 Bevacizumab 20 Nivolumab 19 Specimen Handling 18 Cisplatin 18 Taxes 17 Biopsy 13 Gemcitabine 12 Cyclophosphamide 11 niraparib 10 durvalumab 10 Immunoglobulin G 9 Doxorubicin 9 Disulfides 9 dostarlimab 8 atezolizumab 8 Surveys and Questionnaires 8 Letrozole 8 Brachytherapy 8 Radiotherapy 7 liposomal doxorubicin 6 lenvatinib 6 Platinum 6 Observation 6 Docetaxel 6 fludarabine 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06771596 2025-01-13

CC11

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase 2 Active not recruiting

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡